Back to top

Roth MKM Reaffirms Their Buy Rating on Insmed (INSM)

In a report released today, Adam Walsh from Roth MKM reiterated a Buy rating on Insmed, with a price target of $212.00. According to TipRanks, Wals...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Insmed, Inc. (INSM)